x
|
Quarterly
Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934
|
Delaware
|
84-1374613
|
(State
or other jurisdiction of
incorporation
or organization)
|
(IRS
Employer
Identification
No.)
|
13855
Stowe Drive, Poway, California 92064
|
|
(Address
of principal executive offices)
|
PART
I -- FINANCIAL INFORMATION
|
1
|
ITEM
1. FINANCIAL STATEMENTS
|
1
|
Consolidated
Balance Sheets
|
1
|
Consolidated
Statements of Operations
|
2
|
Consolidated
Statements of Cash Flows
|
3
|
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
|
5
|
ITEM
2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS
|
15
|
Overview
|
15
|
Financing
|
16
|
Selection of Significant Contracts | 17 |
Results
of Operations
|
21
|
Liquidity
and Capital Resources
|
27
|
Critical
Accounting Standards
|
28
|
Recent
Accounting Pronouncements
|
29
|
Risk
Factors
|
29
|
ITEM
4. CONTROLS AND PROCEDURES
|
44
|
PART
II -- OTHER INFORMATION
|
45
|
ITEM
1. LEGAL PROCEEDINGS
|
45
|
ITEM
2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF
PROCEEDS
|
45
|
ITEM
3. DEFAULTS UPON SENIOR SECURITIES
|
45
|
ITEM
4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY
HOLDERS
|
45
|
ITEM
5. OTHER INFORMATION
|
45
|
ITEM
6. EXHIBITS
|
46
|
SIGNATURES
|
46
|
(Unaudited)
|
(Audited)
|
|||||||
September
30, 2008
|
December
31, 2007
|
|||||||
Assets
|
||||||||
Current
Assets
|
||||||||
Cash
|
$ | 5,802,077 | $ | 6,521,003 | ||||
Accounts
receivable, net (Note 2(d))
|
4,483,032 | 5,019,600 | ||||||
Costs
in excess of billings (Note 2(b))
|
658,843 | 1,413,685 | ||||||
Inventory
(Note 2(b))
|
1,130,934 | 1,006,229 | ||||||
Other
current assets (Note 6(a))
|
456,579 | 702,120 | ||||||
Total
Current Assets
|
12,531,465 | 14,662,637 | ||||||
Fixed Assets -
Net
|
5,095,024 | 4,420,020 | ||||||
Intangible
Assets
|
789,032 | 746,392 | ||||||
Goodwill
(Note 5)
|
11,875,331 | 11,233,665 | ||||||
Other
Assets (Note 6(b))
|
1,003,377 | 1,045,272 | ||||||
Total
Assets
|
$ | 31,294,229 | $ | 32,107,986 | ||||
Liabilities
and Stockholders' Equity
|
||||||||
Current
Liabilities
|
||||||||
Accounts
payable and accrued expenses (Note 3(a))
|
$ | 1,734,197 | $ | 1,491,116 | ||||
Current
portion of notes payable and capitalized lease obligations
|
217,495 | 162,885 | ||||||
Accrued
payroll, vacation and related taxes
|
1,189,446 | 1,424,462 | ||||||
Billings
in excess of costs (Note 2(a))
|
1,835,251 | 2,463,366 | ||||||
Other
accrued liabilities (Notes 2(a) and 3)
|
1,022,912 | 1,632,768 | ||||||
Total
Current Liabilities
|
5,999,301 | 7,174,597 | ||||||
Notes
Payable and Capitalized Lease Obligations, Less Current
Maturities
|
767,616 | 343,621 | ||||||
Deferred
Gain - Assets held for sale (Note 3(a))
|
508,179 | 596,133 | ||||||
Other
Long Term Liabilities (Note 3)
|
693,660 | 643,168 | ||||||
Total
Liabilities
|
7,968,756 | 8,757,519 | ||||||
Commitments
and Contingencies
|
||||||||
Stockholders’
Equity
|
||||||||
Convertible
preferred stock, $0.001 par value, 10,000,000 shares
|
||||||||
authorized,
and 250,291 and 251,659 shares issued and outstanding,
|
||||||||
respectively
(Note 4)
|
||||||||
Series
C Convertible preferred stock (Note 4(a))
|
248 | 248 | ||||||
Series
D-1 Convertible preferred stock (Note 4(b))
|
2 | 3 | ||||||
Common
stock, $0.0001 par value; 100,000,000 shares authorized,
and
|
||||||||
43,528,769
and 42,306,871 shares issued and outstanding,
|
||||||||
respectively
(Note 4)
|
4,353 | 4,231 | ||||||
Additional
paid-in capital
|
40,194,274 | 40,441,249 | ||||||
Accumulated
deficit
|
(16,873,404 | ) | (17,095,264 | ) | ||||
Total
Stockholders’ Equity
|
23,325,473 | 23,350,467 | ||||||
Total
Liabilities and Stockholders' Equity
|
$ | 31,294,229 | $ | 32,107,986 | ||||
Three
Months Ended
|
Nine
Months Ended
|
|||||||||||||||||||||||||||||||
September
30,
|
2008
|
%
|
2007
|
%
|
2008
|
%
|
2007
|
%
|
||||||||||||||||||||||||
Net
Sales
|
$ | 9,042,268 | 100.0 | % | $ | 7,606,322 | 100.0 | % | $ | 28,261,633 | 100.0 | % | $ | 25,310,938 | 100.0 | % | ||||||||||||||||
Total
Cost of Sales*
|
7,263,658 | 80.3 | % | 5,402,113 | 71.0 | % | 22,023,363 | 77.9 | % | 18,519,652 | 73.2 | % | ||||||||||||||||||||
Gross
Margin
|
1,778,610 | 19.7 | % | 2,204,209 | 29.0 | % | 6,238,270 | 22.1 | % | 6,791,286 | 26.8 | % | ||||||||||||||||||||
Operating
Expenses
|
||||||||||||||||||||||||||||||||
Marketing
and sales
|
811,384 | 9.0 | % | 796,695 | 10.5 | % | 2,271,189 | 8.0 | % | 2,189,571 | 8.7 | % | ||||||||||||||||||||
Research
and development
|
169,446 | 1.9 | % | 101,890 | 1.3 | % | 622,913 | 2.2 | % | 265,045 | 1.0 | % | ||||||||||||||||||||
General
and administrative
|
449,728 | 5.0 | % | 1,141,599 | 15.0 | % | 2,758,020 | 9.8 | % | 3,798,169 | 15.0 | % | ||||||||||||||||||||
Total
Operating Expenses*
|
1,430,558 | 15.8 | % | 2,040,184 | 26.8 | % | 5,652,122 | 20.0 | % | 6,252,785 | 24.7 | % | ||||||||||||||||||||
Income
from Operations
|
348,052 | 3.8 | % | 164,025 | 2.2 | % | 586,148 | 2.1 | % | 538,501 | 2.1 | % | ||||||||||||||||||||
Non-Operating
Income/(Expense)
|
||||||||||||||||||||||||||||||||
Interest
and other income
|
22,233 | 0.2 | % | 13,868 | 0.2 | % | 83,004 | 0.3 | % | 44,847 | 0.2 | % | ||||||||||||||||||||
Interest
and other expense
|
(45,929 | ) | -0.5 | % | (63,104 | ) | -0.8 | % | (88,440 | ) | -0.3 | % | (196,417 | ) | -0.8 | % | ||||||||||||||||
Gain
on building sale (Note 3(a))
|
29,318 | 0.3 | % | 29,319 | 0.4 | % | 87,952 | 0.3 | % | 87,955 | 0.3 | % | ||||||||||||||||||||
Loan
fee (Note 3(b))
|
(49,635 | ) | -0.5 | % | (86,302 | ) | -1.1 | % | (148,814 | ) | -0.5 | % | (259,865 | ) | -1.0 | % | ||||||||||||||||
Total
Non-Operating Income/(Expense)
|
(44,013 | ) | -0.5 | % | (106,219 | ) | -1.4 | % | (66,298 | ) | -0.2 | % | (323,480 | ) | -1.3 | % | ||||||||||||||||
Income
Before Taxes
|
304,039 | 3.4 | % | 57,806 | 0.8 | % | 519,850 | 1.8 | % | 215,021 | 0.8 | % | ||||||||||||||||||||
Income
tax provision
|
10,700 | 0.1 | % | - | 0.0 | % | 21,915 | 0.1 | % | 800 | 0.0 | % | ||||||||||||||||||||
Net
Income
|
$ | 293,339 | 3.2 | % | $ | 57,806 | 0.8 | % | $ | 497,935 | 1.8 | % | $ | 214,221 | 0.8 | % | ||||||||||||||||
Net
Income
|
293,339 | 57,806 | 497,935 | 214,221 | ||||||||||||||||||||||||||||
Less
Preferred dividend payments
|
(80,979 | ) | (133,462 | ) | (276,075 | ) | (416,096 | ) | ||||||||||||||||||||||||
Net Income (Loss) Available to Common Stockholders
|
212,360 | (75,656 | ) | 221,860 | (201,875 | ) | ||||||||||||||||||||||||||
Net
Income Per Share:
|
$ | 0.00 | $ | (0.00 | ) | $ | 0.01 | $ | (0.01 | ) | ||||||||||||||||||||||
Weighted-Average
Shares Outstanding
|
43,337,330 | 30,914,735 | 42,841,536 | 30,044,852 | ||||||||||||||||||||||||||||
Fully
Diluted Net Income (Loss) Per Share:
|
$ | 0.00 | $ | (0.00 | ) | $ | 0.00 | $ | (0.01 | ) | ||||||||||||||||||||||
Fully
Diluted Weighted-Average Shares Outstanding
|
43,563,060 | 30,914,735 | 47,724,890 | 30,044,852 | ||||||||||||||||||||||||||||
*
The following table shows how the Company's stock option expense would be
allocated to all expenses.
|
||||||||||||||||||||||||||||||||
Cost
of sales
|
$ | 52,529 | $ | 84,701 | $ | 182,040 | $ | 162,074 | ||||||||||||||||||||||||
Marketing
and sales
|
16,219 | 25,536 | 28,277 | 58,864 | ||||||||||||||||||||||||||||
Research
and development
|
- | - | - | - | ||||||||||||||||||||||||||||
General
and administrative
|
95,103 | (20,197 | ) | 209,962 | 81,206 | |||||||||||||||||||||||||||
Total
Non-Cash Stock Option Expense
|
$ | 163,851 | $ | 90,040 | $ | 420,279 | $ | 302,144 |
Nine
Months Ended September 30,
|
2008
|
2007
|
||||
Cash
Flows From Operating Activities
|
||||||
Net
income
|
$ 497,935
|
$ 214,221
|
||||
Adjustments
to reconcile net income to net cash provided by
|
||||||
operating
activities:
|
||||||
Depreciation
and amortization
|
1,045,366
|
887,031
|
||||
Gain
on disposal of building sale
|
(87,954)
|
(87,954)
|
||||
Stock
option expense
|
420,279
|
302,144
|
||||
Non-cash
loan fee amortization
|
212,500
|
259,865
|
||||
Change
in operating assets and liabilities
|
114,647
|
(2,355,154)
|
||||
Net
Cash Provided By (Used in) Operating Activities
|
2,202,773
|
(779,848)
|
||||
Goodwill
|
(116,667)
|
-
|
||||
Other
intangible assets
|
(133,645)
|
-
|
||||
Purchases
of fixed assets
|
(939,192)
|
(881,517)
|
||||
Net
Cash Used in Investing Activities
|
(1,189,504)
|
(881,517)
|
||||
Cash
Flows From Financing Activities
|
||||||
Principal
payments on notes payable and capitalized lease
obligations
|
(211,568)
|
(41,415)
|
||||
Dividend
payments on Series C and Series D-1 preferred stock
|
(314,421)
|
(436,604)
|
||||
Proceeds
from revolving credit facility
|
-
|
1,984,402
|
||||
Employee
stock purchase plan
|
59,791
|
49,802
|
||||
(Repurchase)
Issuance of preferred stock
|
(1,361,111)
|
(859,329)
|
||||
Proceeds
from issuance of common stock
|
95,114
|
4,618,674
|
||||
Net
Cash (Used in) Provided by Financing Activities
|
(1,732,195)
|
5,315,530
|
||||
Net
(Decrease) Increase in Cash
|
(718,926)
|
3,654,166
|
||||
Cash
at Beginning of Period
|
6,521,003
|
1,438,146
|
||||
Cash
at End of Period
|
$ 5,802,077
|
$ 5,092,312
|
||||
Nine
Months Ended September 30,
|
2008
|
2007
|
||||
Supplemental
Disclosures of Cash Flow Information:
|
||||||
Cash
paid during the period for:
|
||||||
Interest
expense
|
$ 32,669
|
$ 18,471
|
||||
Taxes
|
$ 21,915
|
$ 800
|
||||
Noncash
Investing and Financing Activities:
|
||||||
During
the nine months ended September 30, 2008 and 2007, the Company
entered into capital leases in
the amount of approximately $690,000 and $190,000, respectively.
|
||||||
During the nine
months ended September 30, 2008 and 2007, the Company converted $73,866
and $92,577 of employee stock purchase plan contributions into 132,099 and
126,351 shares of common stock, respectively.
|
||||||
During
the nine months ended September 30, 2008 and 2007, the Company converted
$73,866 and $92,577 of
employee stock purchase plan contributions into 132,099 and 126,351 shares
of common stock, respectively.
|
||||||
During
the nine months ended September 30, 2008, the Company issued 833,333
shares of its common stock related
to the Starsys earnout settlement valued at approximately $525,000.
|
Inventory
|
September
30, 2008
|
December
31, 2007
|
||||||
Raw
Material
|
$ | 684,518 | $ | 570,432 | ||||
Work
in Progress
|
220,415 | 528,614 | ||||||
Finished
Goods
|
381,001 | 62,183 | ||||||
Subtotal
|
1,285,934 | 1,161,229 | ||||||
Inventory
Allowance
|
(155,000 | ) | (155,000 | ) | ||||
Inventory,
Net
|
$ | 1,130,934 | $ | 1,006,229 |
September
30, 2008
|
December
31, 2007
|
|
Balance
at January 1
|
$ 505,984
|
76,000
|
Accruals
during the period
|
-
|
557,187
|
Reductions
during the period
|
(159,106)
|
(127,203)
|
Balance
|
$ 346,877
|
$ 505,984
|
Other
Accrued Liabilities at
|
September
30, 2008
|
December
31, 2007
|
||||||
Warranty
accrual
|
$ | 346,877 | $ | 505,984 | ||||
Employee
accruals
|
153,871 | 125,000 | ||||||
Legal,
royalty and customer accuals
|
151,526 | 125,664 | ||||||
Customer
deposits and other accruals
|
119,723 | 348,054 | ||||||
Provision
for anticipated loss
|
71,995 | 315,544 | ||||||
Dividend
(Series D-1 preferred stock)
|
38,070 | 76,475 | ||||||
Property
and income tax accruals
|
49,872 | 30,993 | ||||||
Deferred
rent
|
37,483 | 37,483 | ||||||
Dividend
(Series C preferred stock)
|
42,898 | 42,899 | ||||||
Employee
Stock Purchase Plan
|
10,597 | 24,672 | ||||||
Total
other accrued liabilities
|
$ | 1,022,912 | $ | 1,632,768 |
Long
Term Other Accrued Liabilities at
|
September
30, 2008
|
December
31, 2007
|
Long
term portion of deferred rent
|
$ 693,660
|
$ 643,168
|
Other
Current Assets at
|
September
30, 2008
|
December
31, 2007
|
|
Financing
fees
|
$ 111,764
|
$ 421,986
|
|
Software
prepaid license
|
115,499
|
152,219
|
|
Rental
prepaid short term
|
78,573
|
78,573
|
|
Insurance
prepaid
|
54,947
|
27,585
|
|
All
other short term deposits
|
76,201
|
19,110
|
|
Property
tax prepayment
|
19,595
|
2,647
|
|
Total
Other Current Assets
|
$ 456,579
|
$ 702,120
|
Other
Assets at
|
September
30, 2008
|
December
31, 2007
|
|
Louisville
facility letter of credit
|
$ 550,352
|
$ 535,669
|
|
Deposits
|
346,224
|
339,683
|
|
Deferred
expenses
|
106,801
|
169,920
|
|
Total
Other Assets
|
$ 1,003,377
|
$ 1,045,272
|
·
|
General
and administrative expenses decreased approximately $1.0 million from
approximately $3.8 million for the nine months ended September 30, 2007 to
approximately $2.8 million for the same nine month period in
2008. The decrease can be attributed to the improved
efficiencies of sharing certain General and Administrative services
companywide rather than supported at each location, including but not
limited to accounting support, information systems support and contract
support. General and administrative expenses as a percentage of
total net sales declined from 15.0% for the nine months ended September
30, 2007 to 9.8% for the same nine month period in
2008.
|
·
|
Research
and development expenses increased to approximately $623,000, or 2.2% of
net sales, for the nine months ended September 30, 2008, from
approximately $265,000, or 1.0% of net sales, during the same period in
2007. This increase of internally funded research and
development was focused on programs to enhance our satellite capabilities
and mechanical systems, including but not limited to our in house
development of guidance and navigational control systems, small satellite
production, and enhanced dual-axis pointing mechanism
project.
|
·
|
Marketing
and sales expenses increased to approximately $2.3 million, or 8.0% of net
sales, for the nine months ended September 30, 2008, from approximately
$2.2 million, or 8.7% of net sales, during the same period in
2007. The increase was mainly due to engineering support of new
proposal development.
|
·
|
Our
stock option expense is based on a calculation using the minimum value
method as prescribed by SFAS 123(R), otherwise known as the Black-Scholes
method. Under this method, we used a risk-free interest
rate at the date of grant, an expected volatility, an expected dividend
yield and an expected life of the options to determine the fair value of
options granted. The risk-free interest rate was estimated and
ranged from 2.17% to 4.75%, expected volatility ranged from 48.60% to
94.36% at the time all options were granted, the dividend yield was
assumed to be zero, and the expected life of the options was assumed to be
four years based on the average vesting period of options
granted. The total expense for the nine months ended September
30, 2008 and 2007 was approximately $0.4 million and $0.3 million,
respectively.
|
·
|
We
recorded loan fees related to our revolving credit facility of
approximately $149,000 and $260,000 for the nine months ended September
30, 2008 and 2007, respectively. We issued 310,009 shares of
our common stock, valued at $0.35 million, to Laurus in September 2006 for
revolving credit facility loan fees, which we amortized over the initial
12 months. We further issued 283,286 shares of our common
stock, valued at $0.2 million, to Laurus in September 2007 for revolving
credit facility loan fees, which we amortized from October 2007 through
September 2008.
|
·
|
Interest
and other expense for the nine months ended September 30, 2008 and 2007
was approximately $88,000 and $196,000, respectively. The
decrease was mainly attributable to utilization of our revolving credit
facility in 2007; whereas, we did not utilize the revolving line of credit
during in 2008. Interest and other expenses also includes cash
fees of $175,000, which we are amortizing over 36 months, in connection to
our revolving credit facility mentioned above, which we are
required to expense whether we utilize the facility or not. We
generated interest and other income for the nine months ended September
30, 2008 and 2007 of approximately $83,000 and $45,000, respectively,
based on the levels of our cash balances in each period and other
non-operating income.
|
·
|
We
recognized approximately $88,000 of the deferred gain on the 2003 sale of
our Poway headquarters building during each of the nine month periods
ended September 30, 2008 and 2007, and we will continue to amortize the
remaining deferred gain of approximately $0.5 million into non-operating
income over the remainder of the leaseback period, which expires in
January 2013.
|
For
the nine months ending
|
September
30, 2008
|
September
30, 2007
|
|
(Unaudited)
|
(Unaudited)
|
||
Net
Income
|
$ 497,935
|
$ 214,221
|
|
Interest
and other Income
|
(83,004)
|
(44,847)
|
|
Interest
and other Expense
|
88,440
|
196,417
|
|
Provision
for Income Taxes
|
21,915
|
800
|
|
Depreciation
and Amortization
|
1,045,365
|
887,031
|
|
Loan
Fees on Revolving Credit Facility
|
148,814
|
259,865
|
|
Stock
Option Expense
|
420,279
|
302,144
|
|
Gain
on Building Sale
|
(87,952)
|
(87,955)
|
|
Adjusted
EBITDA
|
$ 2,051,792
|
$ 1,727,675
|
·
|
Adjusted
EBITDA is used by management as a performance measure for benchmarking
against our peers and our competitors. In particular, we
evaluate management performance by using revenues and operating income
(loss) before depreciation and amortization, loan fees on our revolving
credit facility, stock option expense, and gain on our 2003 building
sale. We also use Adjusted EBITDA to evaluate operating
performance, to measure performance for incentive compensation programs,
and to evaluate future growth
opportunities.
|
·
|
Adjusted
EBITDA is one of the metrics used by management and our Board of
Directors, to review the financial performance of the business on a
monthly basis and, in part, to determine the level of compensation for
management. This is done by comparing the managers’
departmental budgets without interest, taxes, depreciation and
amortization, loan fees on our revolving credit facility, stock option
expense, and gain on our 2003 building sale as a measure of their
performance.
|
·
|
We
believe Adjusted EBITDA is useful to investors and allows a comparison of
our operating results with that of competitors exclusive of depreciation
and amortization, interest income, interest expense, non-cash stock option
expenses and other non-operating expenses such as loan fees and gain on
our 2003 building sale. Financial results of competitors in our
industry have significant variations that can result from timing of
capital expenditures, the amount of intangible assets recorded, the
differences in assets’ lives, the timing and amount of investments and the
variances in the amount of stock options granted to
employees.
|
·
|
General
and administrative expenses decreased approximately $0.7 million from
approximately $1.1 million for the three months ended September 30, 2007
to approximately $0.4 million for the same three month period in
2008. The decrease can be attributed mainly to adjustments in
our general and administrative rates, and to a lesser extent, improved
efficiencies of sharing certain General and Administrative services
companywide rather than supported at each location, including but not
limited to accounting support, information systems support and contract
support. General and administrative expenses as a percentage of total net
sales decreased from 15.0% for the three months ended September 30, 2007
to 5.0% for the same three month period in
2008.
|
·
|
Research
and development expenses increased to approximately $0.2 million, or 1.9%
of net sales, for the three months ended September 30, 2008, from
approximately $0.1 million, or 1.3% of net sales, of net sales, during the
same period in 2007. This increase of internally funded
research and development related to programs which enhanced our satellite
capabilities and mechanical systems, including but not limited to our in
house development of guidance and navigational control systems, small
satellite production, and an enhanced dual-axis pointing mechanism
project.
|
·
|
Marketing
and sales expenses remained essentially flat at approximately $0.8
million, or 9.0% of net sales, for the three months ended September 30,
2008, from approximately $0.8 million, or 10.5% of net sales, during the
same period in 2007.
|
·
|
Our
stock option expense is based on a calculation using the minimum value
method as prescribed by SFAS 123(R), otherwise known as the Black-Scholes
method. Under this method, we used a risk-free interest
rate at the date of grant, an expected volatility, an expected dividend
yield and an expected life of the options to determine the fair value of
options granted. The risk-free interest rate was estimated and
ranged from 2.62% to 3.11%, expected volatility ranged from 48.60% to
55.83% at the time all options were granted, the dividend yield was
assumed to be zero, and the expected life of the options was assumed to be
four years based on the average vesting period of options
granted. The total expense for the three months ended September
30, 2008 and 2007 was approximately $0.2 million and $0.1 million,
respectively.
|
·
|
We
recorded loan fees related to our revolving credit facility of
approximately $50,000 and $86,000 for the three months ended September 30,
2008 and 2007, respectively. We issued 310,009 shares of our
common stock, valued at $0.35 million, to Laurus in September 2006 for
revolving credit facility loan fees, which we amortized over the initial
12 months. We further issued 283,286 shares of our common
stock, valued at $0.2 million, to Laurus in September 2007 for revolving
credit facility loan fees, which we are amortizing from October 2007
through September 2008.
|
·
|
Interest
and other expense for the three months ended September 30, 2008 and 2007
was approximately $46,000 and $63,000, respectively. The
decrease was mainly attributable to utilization of our revolving credit
facility in 2007; whereas, we did not utilize the revolving line of credit
during in 2008. Interest and other expenses also include cash
fees of $175,000, which we are amortizing over 36 months in connection to
our revolving credit facility mentioned above, which we are required to
expense whether we utilize the facility or not. We generated
interest and other income in the three months ended June 30, 2008 and 2007
of approximately $22,000 and $14,000, respectively, based on the levels of
our cash balances in each period.
|
·
|
We
recognized approximately $29,000 of the deferred gain on the 2003 sale of
our Poway headquarters building during each of the three month periods
ended September 30, 2008 and 2007, and we will continue to amortize the
remaining deferred gain of approximately $0.5 million into non-operating
income over the remainder of the leaseback period, which expires in
January 2013.
|
For
the three months ended
|
September
30, 2008
|
September
30, 2007
|
|
(Unaudited)
|
(Unaudited)
|
||
Net
Income
|
$ 293,339
|
$ 57,806
|
|
Interest
and other Income
|
(22,233)
|
(13,868)
|
|
Interest
and other Expense
|
45,929
|
63,104
|
|
Provision
for Income Taxes
|
10,700
|
-
|
|
Depreciation
and Amortization
|
369,655
|
294,110
|
|
Loan
Fees on Revolving Credit Facility
|
49,635
|
86,302
|
|
Stock
Option Expense
|
163,851
|
90,040
|
|
Gain
on Building Sale
|
(29,318)
|
(29,319)
|
|
Adjusted
EBITDA
|
$ 881,558
|
$ 548,175
|
·
|
Adjusted
EBITDA is used by management as a performance measure for benchmarking
against our peers and our competitors. In particular, we
evaluate management performance by using revenues and operating income
(loss) before depreciation and amortization, loan fees on our revolving
credit facility, stock option expense, and gain on our 2003 building
sale. We also use Adjusted EBITDA to evaluate operating
performance, to measure performance for incentive compensation programs,
and to evaluate future growth
opportunities.
|
·
|
Adjusted
EBITDA is one of the metrics used by management and our Board of
Directors, to review the financial performance of the business on a
monthly basis and, in part, to determine the level of compensation for
management. This is done by comparing the managers’
departmental budgets without interest, taxes, depreciation and
amortization, loan fees on our revolving credit facility, stock option
expense, and gain on our 2003 building sale as a measure of their
performance.
|
·
|
We
believe Adjusted EBITDA is useful to investors and allows a comparison of
our operating results with that of competitors exclusive of depreciation
and amortization, interest income, interest expense, non-cash stock option
expenses and other non-operating expenses such as loan fees and gain on
our 2003 building sale. Financial results of competitors in our
industry have significant variations that can result from timing of
capital expenditures, the amount of intangible assets recorded, the
differences in assets’ lives, the timing and amount of investments and the
variances in the amount of stock options granted to
employees.
|
·
|
the
price of our common stock may decline to the extent that the market price
of our common stock reflected a market assumption that the merger would be
completed;
|
·
|
we
could suffer the loss of customers, revenues and employees due to
uncertainties resulting from an uncompleted merger;
and
|
·
|
our
costs related to the merger, such as legal and advisory fees, must be paid
even if the merger is not completed. Such costs would reduce our reported
earnings or increase our reported loss, for the period when it was
determined that the merger would not be consummated. We estimate that we
will incur aggregate direct transaction costs of between $1.5 million and
$2.0 million associated with the Sierra Nevada merger transaction
including legal fees, and investment banking
costs.
|
·
|
limit
the number of new fixed price development
contracts;
|
·
|
offer
our customers alternative contract structures that better protect
us;
|
·
|
establish
additional costing reviews;
|
·
|
improve
our contract review process and hire contract professionals to review
contracts; and
|
·
|
increase
senior management involvement to scrutinize proposal efforts related to
fixed price contracts.
|
·
|
challenges
encountered in managing larger, more geographically dispersed
operations;
|
·
|
the
loss of key employees;
|
·
|
diversion
of the attention of management from other ongoing business
concerns;
|
·
|
potential
incompatibilities of processes, technologies and
systems;
|
·
|
potential
difficulties integrating and harmonizing financial reporting systems;
and,
|
·
|
potential
failure to implement systems to properly price and manage the execution of
fixed price contracts.
|
·
|
the
operations of our multi-site company does not result in the anticipated
synergies and benefits;
|
·
|
the
costs savings from operational improvements is not greater than
anticipated;
|
·
|
the
combined financial results are not consistent with
expectations;
|
·
|
management
is unable to successfully manage a multi-location
business;
|
·
|
the
anticipated operating and product synergies of our business areas are not
realized; or,
|
·
|
the
fixed price development contracts, or new fixed price contracts, incur
major cost overruns or remain unprofitable for any
reasons.
|
·
|
include
provisions that allow the government agency to terminate the contract
without penalty;
|
·
|
be
subject to purchasing decisions of agencies that are subject to political
influence;
|
·
|
contain
onerous procurement procedures;
and,
|
·
|
be
subject to cancellation if government funding becomes
unavailable.
|
·
|
we
may not be awarded all stages of existing or future
contracts;
|
·
|
significant
contracts may be awarded to our competitors rather than to
us;
|
·
|
the
timing of new technological advances and mission solution announcements or
introductions by us and our
competitors;
|
·
|
changes
in the terms of our arrangements with customers or
suppliers;
|
·
|
reliance
on a few customers for a significant portion of our
revenue;
|
·
|
the
failure of our key suppliers to perform as
expected;
|
·
|
general
or particular political conditions that could affect spending for the
products that we offer;
|
·
|
changes
in perception of the safety of space
travel;
|
·
|
cost
overruns or other delays or failures to satisfy our obligations under our
contracts on a timely basis;
|
·
|
the
failure of our mission solution to conduct a successful
mission;
|
·
|
the
uncertain market for our mission solutions, products, services and
technologies;
|
·
|
the
availability and cost of raw materials and components;
and,
|
·
|
the
potential loss of or inability to hire key
personnel.
|
·
|
problems
assimilating the purchased technologies, products, or business
operations;
|
·
|
problems
maintaining uniform standards, procedures, controls, and
policies;
|
·
|
unanticipated
costs associated with the
acquisition;
|
·
|
diversion
of management's attention from core
businesses;
|
·
|
adverse
effects on existing business relationships with suppliers and
customers;
|
·
|
incompatibility
of business cultures;
|
·
|
risks
associated with entering new markets in which we have no or limited prior
experience;
|
·
|
dilution
of common stock and shareholder value as well as adverse changes in stock
price;
|
·
|
potential
loss of key employees of acquired businesses;
and
|
·
|
increased
legal and accounting costs as a result of the rules and regulations
related to the Sarbanes-Oxley Act of
2002.
|
·
|
deviations
in our results of operations;
|
·
|
changes
in our financial performance or in analyst coverage
decisions;
|
·
|
changes
in our markets, including decreased government spending or the entry of
new competitors;
|
·
|
awards
of significant contracts to competitors rather than to
us;
|
·
|
our
inability to obtain financing necessary to operate our
business;
|
·
|
changes
in technology;
|
·
|
potential
loss of key personnel;
|
·
|
short
selling;
|
·
|
perceptions
about the effect of possible dilution arising from the issuance of large
numbers of shares of common stock underlying outstanding stock options,
warrants, and preferred stock:
|
·
|
changes
in market valuations of similar companies and of stocks
generally;
|
·
|
volume
fluctuations generally; and,
|
·
|
other
factors listed above in our Risk Factor: "Our operating results could
fluctuate on a quarterly and annual basis, which could cause our stock
price to fluctuate or
decline."
|
·
|
make
a special written suitability determination for the
purchaser;
|
·
|
receive
the purchaser's written agreement to a transaction prior to
sale;
|
·
|
provide
the purchaser with risk disclosure documents which identify certain risks
associated with investing in "penny stocks" and which describe the market
for these "penny stocks" as well as a purchaser's legal remedies;
and,
|
·
|
obtain
a signed and dated acknowledgment from the purchaser demonstrating that
the purchaser has actually received the required risk disclosure document
before a transaction in a "penny stock" can be
completed.
|
Exhibit
No.
|
Description
|
10.1
|
Release
entered into as of July 15, 2008 by and between SpaceDev, Inc. and the
Shareholder Agent of Starsys Research Corporation
|
31.1
|
Rule
13a-14(a) certification of Principal Executive Officer
|
31.2
|
Rule
13a-14(a) certification of Principal Financial Officer
|
32.1
|
Rule
13a-14(b) certification of Chief Executive Officer
|
32.2
|
Rule
13a-14(b) certification of Chief Financial
Officer
|